JP7545999B2 - 転写リレー系 - Google Patents

転写リレー系 Download PDF

Info

Publication number
JP7545999B2
JP7545999B2 JP2021570521A JP2021570521A JP7545999B2 JP 7545999 B2 JP7545999 B2 JP 7545999B2 JP 2021570521 A JP2021570521 A JP 2021570521A JP 2021570521 A JP2021570521 A JP 2021570521A JP 7545999 B2 JP7545999 B2 JP 7545999B2
Authority
JP
Japan
Prior art keywords
transcription factor
nucleotide sequence
reporter
nucleic acid
relay system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021570521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536257A (ja
JP2022536257A5 (https=
Inventor
イェン－リー チャン，レオン
ロス クーパー，アーロン
チャン，ヘンリー
Original Assignee
オクタント，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オクタント，インク． filed Critical オクタント，インク．
Publication of JP2022536257A publication Critical patent/JP2022536257A/ja
Publication of JP2022536257A5 publication Critical patent/JP2022536257A5/ja
Application granted granted Critical
Publication of JP7545999B2 publication Critical patent/JP7545999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2021570521A 2019-05-28 2020-05-27 転写リレー系 Active JP7545999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853637P 2019-05-28 2019-05-28
US62/853,637 2019-05-28
PCT/US2020/034685 WO2020243164A1 (en) 2019-05-28 2020-05-27 Transcriptional relay system

Publications (3)

Publication Number Publication Date
JP2022536257A JP2022536257A (ja) 2022-08-15
JP2022536257A5 JP2022536257A5 (https=) 2023-05-15
JP7545999B2 true JP7545999B2 (ja) 2024-09-05

Family

ID=71094844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570521A Active JP7545999B2 (ja) 2019-05-28 2020-05-27 転写リレー系

Country Status (9)

Country Link
US (1) US20220177897A1 (https=)
EP (1) EP3976795A1 (https=)
JP (1) JP7545999B2 (https=)
KR (1) KR20220015443A (https=)
CN (1) CN114585741B (https=)
AU (1) AU2020283935A1 (https=)
CA (1) CA3140902A1 (https=)
MA (1) MA56037A (https=)
WO (1) WO2020243164A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230137387A (ko) * 2021-02-02 2023-10-04 옥탄트, 인크. 세포 신호전달 단백질 활성을 측정하기 위한 시스템 및 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003512827A (ja) 1999-10-25 2003-04-08 ノバルティス アクチエンゲゼルシャフト リガンド活性化転写レギュレータータンパク質
JP2004508288A (ja) 2000-03-31 2004-03-18 ブラウン　ユニバーシティ　リサーチ　ファウンデーション 記憶固定を調節する方法及び組成物
JP2020509850A (ja) 2017-03-07 2020-04-02 パイパー・アクセス、エルエルシー 細長い器具のための安全シールド並びに関連のシステム及び方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6936702B2 (en) 2000-06-07 2005-08-30 Li-Cor, Inc. Charge-switch nucleotides
US20030166555A1 (en) * 2001-04-02 2003-09-04 Alberini Cristina M. Methods and compositions for regulating memory consolidation
CA2513899C (en) 2003-01-29 2013-03-26 454 Corporation Methods of amplifying and sequencing nucleic acids
US7745116B2 (en) 2003-04-08 2010-06-29 Pacific Biosciences Of California, Inc. Composition and method for nucleic acid sequencing
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US7462452B2 (en) 2004-04-30 2008-12-09 Pacific Biosciences Of California, Inc. Field-switch sequencing
US20060024711A1 (en) 2004-07-02 2006-02-02 Helicos Biosciences Corporation Methods for nucleic acid amplification and sequence determination
US7276720B2 (en) 2004-07-19 2007-10-02 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060024678A1 (en) 2004-07-28 2006-02-02 Helicos Biosciences Corporation Use of single-stranded nucleic acid binding proteins in sequencing
CA2579150C (en) 2004-09-17 2014-11-25 Pacific Biosciences Of California, Inc. Apparatus and method for analysis of molecules
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
CA2588122A1 (en) 2004-11-16 2006-05-26 Helicos Biosciences Corporation Tirf single molecule analysis and method of sequencing nucleic acids
US7462468B1 (en) 2005-01-28 2008-12-09 Pacific Biosciences Of California, Inc. DNA intercalating agents and methods of use
US7476504B2 (en) 2005-01-31 2009-01-13 Pacific Biosciences Of California, Inc. Use of reversible extension terminator in nucleic acid sequencing
US20060286566A1 (en) 2005-02-03 2006-12-21 Helicos Biosciences Corporation Detecting apparent mutations in nucleic acid sequences
US7405281B2 (en) 2005-09-29 2008-07-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
US20080269476A1 (en) 2006-04-26 2008-10-30 Helicos Biosciences Corporation Molecules and methods for nucleic acid sequencing
US7767805B2 (en) 2007-05-03 2010-08-03 Helicos Biosciences Corporation Methods and compositions for sequencing a nucleic acid
CN101743329A (zh) * 2007-05-11 2010-06-16 平移基因组学研究所 测定外部刺激对活细胞中生物通路影响的方法
CA2689626C (en) 2007-06-06 2016-10-25 Pacific Biosciences Of California, Inc. Methods and processes for calling bases in sequence by incorporation methods
JP2010534474A (ja) 2007-07-26 2010-11-11 パシフィック バイオサイエンシーズ オブ カリフォルニア， インコーポレイテッド 分子冗長配列決定
CN102643852B (zh) * 2011-02-28 2015-04-08 华东理工大学 光可控的基因表达系统
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
IL260532B2 (en) * 2016-01-11 2023-12-01 Univ Leland Stanford Junior Chimeric proteins- containing systems and uses thereof in regulating gene expression
EP3342868B1 (en) * 2016-12-30 2019-12-25 Systasy Bioscience GmbH Constructs and screening methods
CN107760707B (zh) * 2017-05-25 2020-05-19 西北农林科技大学 一种增强基因表达的自激活Gal4/UAS系统表达盒的建立

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003512827A (ja) 1999-10-25 2003-04-08 ノバルティス アクチエンゲゼルシャフト リガンド活性化転写レギュレータータンパク質
JP2004508288A (ja) 2000-03-31 2004-03-18 ブラウン　ユニバーシティ　リサーチ　ファウンデーション 記憶固定を調節する方法及び組成物
JP2020509850A (ja) 2017-03-07 2020-04-02 パイパー・アクセス、エルエルシー 細長い器具のための安全シールド並びに関連のシステム及び方法

Also Published As

Publication number Publication date
CA3140902A1 (en) 2020-12-03
CN114585741A (zh) 2022-06-03
EP3976795A1 (en) 2022-04-06
AU2020283935A1 (en) 2021-12-23
MA56037A (fr) 2022-04-06
US20220177897A1 (en) 2022-06-09
JP2022536257A (ja) 2022-08-15
KR20220015443A (ko) 2022-02-08
WO2020243164A1 (en) 2020-12-03
CN114585741B (zh) 2026-01-06

Similar Documents

Publication Publication Date Title
US20220162667A1 (en) Systems for protein-protein interaction screening
Gromak et al. The PTB interacting protein raver1 regulates α‐tropomyosin alternative splicing
CN100399028C (zh) 鉴定与跨膜蛋白相互作用的化合物的方法
JP2002510051A (ja) リガンド依存性核内受容体とコアクチベーターの相互作用を検出するための組成物および方法
JP5303448B2 (ja) 親和性が減少した酵素の相補性レポーター系を用いた分子相互作用の検出
Barbeito et al. HTR6 and SSTR3 ciliary targeting relies on both IC3 loops and C-terminal tails
JPH06511386A (ja) リガンドおよびリガンドのアンタゴニストを同定する方法
Heckert et al. Multiple promoter elements contribute to activity of the follicle-stimulating hormone receptor (FSHR) gene in testicular Sertoli cells
WO2003027634A2 (en) Identification of modulatory molecules using inducible promoters
Falkenberg et al. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ
US20100297674A1 (en) NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
Nakadai et al. Two target gene activation pathways for orphan ERR nuclear receptors
Monroy et al. SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1
JP7545999B2 (ja) 転写リレー系
EP2985347B1 (en) Method for detecting protein stability and uses thereof
Nakashima et al. Cell-based assay of nongenomic actions of progestins revealed inhibitory G protein coupling to membrane progestin receptor α (mPRα)
Nieva et al. Impact of heterodimerization on intracellular localization of the ecdysteroid receptor (EcR)
US12590959B2 (en) Systems and methods for measuring cell signaling protein activity
US6472151B1 (en) Method of screening for compounds that modulate the activity of a molecular target
US20250333748A1 (en) A degron for regulating protein expression and methods thereof
Han et al. Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression
US20060269950A1 (en) Method of identifying compounds that modulate interaction of androgen receptor with beta-catenin
Moghis Regulation of apolipoprotein-E by a novel class of compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220506

RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20230111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230428

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240430

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240813

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240826

R150 Certificate of patent or registration of utility model

Ref document number: 7545999

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150